The increase in ABCB1, ABCC1, and ABCG2 expression in NSCLC cultures after treatment with five increasing concentrations of nintedanib is shown in Figure 5, Figure 6, and Figure 7, respectively. Here, ABCB1 is linked to non-small cell lung carcinoma.